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The vaccinia-related kinases (VRKs) comprise a branch of the casein kinase family whose members are characterized by
homology to the vaccinia virus B1 kinase. The VRK orthologues encoded by Caenorhabditis elegans and Drosophila
melanogaster play an essential role in cell division; however, substrates that mediate this role have yet to be elucidated.
VRK1 can complement the temperature sensitivity of a vaccinia B1 mutant, implying that VRK1 and B1 have overlapping
substrate specificity. Herein, we demonstrate that B1, VRK1, and VRK2 efficiently phosphorylate the extreme N terminus
of the BAF protein (Barrier to Autointegration Factor). BAF binds to both DNA and LEM domain–containing proteins of
the inner nuclear membrane; in lower eukaryotes, BAF has been shown to play an important role during the reassembly
of the nuclear envelope at the end of mitosis. We demonstrate that phosphorylation of ser4 and/or thr2/thr3 abrogates the
interaction of BAF with DNA and reduces its interaction with the LEM domain. Coexpression of VRK1 and GFP-BAF
greatly diminishes the association of BAF with the nuclear chromatin/matrix and leads to its dispersal throughout the cell.
Cumulatively, our data suggest that the VRKs may modulate the association of BAF with nuclear components and hence
play a role in maintaining appropriate nuclear architecture.
INTRODUCTION
Dynamic protein phosphorylation is mediated by the actions
of numerous protein kinases and protein phosphatases. The
centrality of this modification as a modulator of cellular
function is underscored by the observation that the human
genome is thought to encode 600 kinases and perhaps
one-third that many phosphatases (Manning et al., 2002;
MacKeigan et al., 2005). Phosphorylation can modulate such
diverse properties as protein localization, protein turnover,
enzymatic activity, and protein–protein and protein–nucleic
acid interaction. Our laboratory has recently become inter-
ested in a family of three proteins known as VRKs, or
vaccinia-related kinases, which exhibit a high degree of ho-
mology to the B1 protein kinase encoded by vaccinia virus
(Nezu et al., 1997; Zelko et al., 1998; Nichols and Traktman,
2004). B1 plays a poorly understood, but essential, role in
enabling viral DNA replication to occur; temperature-sensi-
tive mutants affected in B1 fail to accomplish DNA replica-
tion at the nonpermissive temperature (Rempel and Traktman,
1992). Interestingly, we have shown that expression of en-
zymatically active VRK1 from the tsB1 vaccinia virus ge-
nome restores viral DNA replication, whereas a catalytically
inactive mutant of VRK1 cannot rescue the virus (Boyle and
Traktman, 2004). Thus, B1 and VRK1 must share common
substrate(s) whose phosphorylation is required for viral rep-
lication to occur.
We have therefore initiated further studies of the VRKs as
a means to understand the role of B1 and vice versa. Mam-
malian genomes encode three VRK proteins: VRK1, which is
nuclear and enzymatically active; VRK2, which associates
with the endoplasmic reticulum (ER) and nuclear envelope
and is enzymatically active; and VRK3, which is nuclear and
enzymatically inactive due to key amino acid substitutions
in catalytic domains (Nichols and Traktman, 2004). Al-
though the participation of VRK1 in the phosphorylation of
stress-related transcription factors has been documented
(Lopez-Borges and Lazo, 2000; Barcia et al., 2002; Vega et al.,
2004; Sevilla et al., 2004a, 2004b), a full appreciation of the
biological roles of the VRK proteins awaits genetic dissec-
tion. In contrast, recent genetic and pseudogenetic studies of
Caenorhabditis elegans and Drosophila melanogaster, each of
which encodes a single VRK ortholog, have provided signif-
icant clues as to the cellular function of these proteins. The
D. melanogaster VRK gene, named ballchen/NHK1, has been
shown to encode a protein that possesses histone phosphor-
ylation activity (Aihara et al., 2004). Furthermore, a strain
with a hypomorphic mutation in NHK1 shows a recessive
phenotype characterized by sterility in both male and female
flies due to defects in meiotic spindle formation (Ivanovska
et al., 2005). Other independently isolated NHK1 mutations
result in flies having oocytes with multiple spindles and
increased chromosome condensation during prophase
(Cullen et al., 2005). NHK1 hypomorphs also display mitotic
defects such as increased mitotic index, overcondensation of
chromosomes, and aberrant spindle formation (Ivanovska et
al., 2005; Cullen et al., 2005). The function of the C. elegans
VRK homolog has been ablated through the use of siRNA-
mediated depletion; loss of the VRK protein results in early
embryonic lethality. These embryos arrest at the earliest cell
division, unable to complete nuclear division and cytokine-
sis (www.wormbase.org).
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One of the most important but also most daunting chal-
lenges posed by the study of protein kinases is the identifi-
cation of bona fide substrates. The studies described in this
article emerged from our attempt to screen for cellular sub-
strates that could be phosphorylated by both B1 and VRK1.
Using this approach, we have identified the barrier to auto-
integration factor (BAF) as a substrate for VRK1, VRK2, and
the B1 kinase. BAF is a 10-kDa protein that was originally
identified in mammalian cells by virtue of its association
with the preintegration complexes (PICs) of retroviruses
(Lee and Craigie, 1998). In the cytoplasm, it appears to bind
to the proviral DNA within the PICs and prevent autointe-
gration (Lee and Craigie, 1994, 1998); once within the nu-
cleus, it appears to facilitate the integration of the proviral
DNA into the host chromosome (Suzuki and Craigie, 2002).
The functional form of BAF is a homodimer that binds to
double-stranded DNA in a sequence-independent manner,
making contacts with the phosphate backbone at the minor
groove (Zheng et al., 2000; Bradley et al., 2005). BAF dimers
are capable of associating with DNA in higher order struc-
tures, which can lead to cross-bridging and condensation of
the DNA (Lee and Craigie, 1998; Zheng et al., 2000; Suzuki
and Craigie, 2002). The solution structure of BAF has been
solved by NMR spectroscopy (Cai et al., 1998) and the crystal
structure of BAF bound to DNA has very recently been
reported (Bradley et al., 2005).
In addition to binding to DNA, BAF can bind to protein
components of the inner nuclear membrane (INM) via their
LEM domains (Furukawa, 1999; Lee et al., 2001; Shumaker et
al., 2001; Holaska et al., 2003; Mansharamani and Wilson,
2005). The latter domain was originally identified in the
Lap2, emerin, and MAN1 proteins (Lin et al., 2000). The
simultaneous interaction with both DNA and these INM
proteins underlies the proposed functions of BAF in inter-
phase and mitosis (Shumaker et al., 2001; Shimi et al., 2004).
During interphase, BAF is found predominantly at the INM
(Shimi et al., 2004), where it is thought to assist in the
anchoring of chromatin to the nuclear periphery. As cells
enter mitosis, BAF assumes a diffuse localization, until it
begins to colocalize with the core region of chromosome
telomeres at late anaphase (Haraguchi et al., 2001; Shimi et
al., 2004). At this stage, BAF has been shown to be essential
for reassembly of the nuclear envelope, perhaps by recruit-
ing the INM proteins to the membranes that coalesce around
the segregating chromosomes (Haraguchi et al., 2001).
BAF is also conserved in lower eukaryotes, and has been
studied in both C. elegans and D. melanogaster. Genetic and
pseudogenetic studies of BAF in these organisms also pro-
vide experimental support for a role for BAF during mitosis
(Furukawa et al., 2003). When the D. melanogaster BAF gene
was mutated by imprecise P element excision, the resulting
null mutants had an embryonic lethal phenotype character-
ized by mitotic dysfunction (Furukawa et al., 2003). In addi-
tion, aberrations in the appearance of interphase chromatin
were observed (Furukawa et al., 2003). RNAi-mediated de-
pletion of the BAF protein in C. elegans also engendered an
embryonic lethal phenotype before the 100-cell stage (Margalit
et al., 2005). The two most striking features of these embryos
were the presence of anaphase chromatin bridges and the
aberrant condensation of interphase chromatin (Margalit et al.,
2005). In sum, these data provide strong support for a role for
BAF in the intranuclear organization of chromatin and the
enclosure of chromosomes within the reassembling nuclear
envelope. BAF has also been shown to be essential for the
localization of the LEM domain–containing proteins to the
inner nuclear envelope; in presence of a dominant negative
BAF (G25E), these proteins are retained in the ER during nu-
clear reassembly (Haraguchi et al., 2001). These data under-
score the importance of BAF in the maintenance of a correct
nuclear architecture.
The model described above implies that the association of
BAF with chromosomes and with the proteins of the INM
must change as the cell cycle progresses. We speculated that
protein phosphorylation might modulate these interactions.
The studies described herein demonstrate that, in vitro, the
VRK enzymes can phosphorylate the N terminus of BAF in
a manner that has a modest effect on the interaction of BAF
with LEM domain–containing proteins, and a dramatic ef-
fect on its interaction with DNA. Strikingly, VRK1 can mod-
ulate the phosphorylation status and the intracellular local-
ization of BAF in vivo.
MATERIALS AND METHODS
Cell Culture and Reagents
Human thymidine kinase-negative 143B osteosarcoma cells (TK) and Afri-
can green monkey BSC40 kidney epithelial cells were maintained as mono-
layers in DMEM, supplemented with 5% fetal bovine serum (FBS; GIBCO/
Invitrogen, Carlsbad, CA) in the presence of 5% CO2. Human osteosarcoma
U2OS cells (kindly provided by J. L. Taylor, Medical College of Wisconsin)
were maintained in DMEM with 10% FBS. All chemicals were of ultrapure
quality from Sigma-Aldrich (St. Louis, MO). Enzymes for nucleic acid ma-
nipulation were from Roche (Indianapolis, IN) or Invitrogen. Purified GST-
p53 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
[-32P]ATP and 32PPi were obtained from Perkin Elmer-Cetus (Boston, MA).
The following plasmids were used in this study: p3XFLAG-7.1 (Sigma),
pAcGFP1-C3 (Clontech, Palo Alto, CA), pET15b (Novagen, Madison, WI),
pGEX6P-1 (Amersham, Piscataway, NJ) and pTM1–3XFLAG (Nichols and
Traktman, 2004; Punjabi and Traktman, 2005). The following commercial
antibodies were used in this study: rabbit -GST (Zymed; San Francisco, CA),
affinity-purified M2 -FLAG monoclonal antibody (mAb; Sigma), and 4A6
-Myc (Upstate, Lake Placid, NY). Oligonucleotides were purchased from
Integrated DNA Technologies (Coralville, IA). -BAF sera were generous gifts
from Katherine Wilson (Johns Hopkins Medical School, Baltimore, MD) and
Kazuhiro Furukawa (Niigata University, Japan).
Plasmid Construction
Construction of Plasmids for Expression of WT and Mutant BAF Proteins.
1) BAF in vitro expression plasmid: The BAF open reading frame (ORF) was PCR
amplified from oligo dT-primed cDNA generated from hTK-143 RNA as de-
scribed (Nichols and Traktman, 2004), using BAFMTTSQUP and BAF DN. The
product was digested with NdeI/BamHI and ligated with pTM1–3XFLAG di-
gested similarly and treated with calf intestinal alkaline phosphatase (CIP). 2)
BAF bacterial expression plasmids: pET15b-BAF was generously provided by Dr.
Robert Craigie (NIH). Mutations at the amino terminus of BAF were introduced
by PCR amplification with BAF-DN in combination with the appropriate up-
stream mutagenic primer BAFmxxxq-UP (Table 1). PCR products were digested
with NdeI/BamHI and ligated with pET15b plasmid that had been digested
similarly and treated with CIP. Transformants of the BL21(DE3)pLysS strain of E.
coli were generated and used for BAF expression. 3) BAF eukaryotic
expression constructs: For expression in mammalian cells, wild-type (WT)
BAF was amplified with BAF-DN and the appropriate upstream muta-
genic primer BAFmxxxq-UP (Table 1); these PCR products were digested
with HindIII/BamHI and ligated to p3XFLAG or pAcGFP1-C3 plasmid
DNA that been similarly digested and treated with CIP.
Construction of Plasmids for Expression of Emerin. GST-LEM: The emerin
ORF was amplified by PCR using oligo dT-primed cDNA generated from
hTK-143 RNA with the Emerin-UP1 and Emerin-DN primers. This product
was digested with HindIII/BamHI and cloned into a similarly digested
p3XFLAG vector. This plasmid served as the template for PCR amplification
with Emerin-UP2 and Emerin LEM-DN primers; the 183-base pair product,
which encodes 61 amino acids that encompass the LEM domain, was digested
with BamHI. This product was ligated with pGEX6P-1 vector DNA that had
been previously digested with BamHI and treated with CIP, generating the
plasmid pGST-LEM. E. coli BL21 transformants containing pGST-LEM were
generated and used for protein expression.
Construction of a Catalytically Inactive hVRK1 cDNA Allele. Using overlap
PCR, the aspartic acid residue at amino acid 177 was altered to alanine. To
produce this mutation, two sets of primer pairs were used to amplify the
target region; 1) D177A DN introduced the sense strand mutation and was
used with hVRK1Asp-UP, and 2) D177A-UP introduced the complement of the
mutation and was used with hVRK1-DN. The pcDNA3-hVRK1MYC (Nichols
R. J. Nichols et al.
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and Traktman, 2004) plasmid was used as the template for these PCRs. A
mixture of the PCR products from the two reactions served as the template in
a second round of amplification performed with hVRK1Asp-UP and hVRK1-
DN. The final product was digested with Asp718/BamHI and ligated with
p3XFLAG that had been similarly digested and treated with CIP. A plasmid
expressing a 3XFLAG-tagged version of WT VRK1 was amplified using the
same outside primers and cloned into the same vector.
Purification of Recombinant Proteins
The purification of recombinant vvB1, hVRK1, and hVRK2 was performed as
previously described (Nichols and Traktman, 2004). Recombinant WT BAF
and mutant derivatives were prepared from the insoluble fraction of induced
cultures essentially as described (Lee and Craigie, 1998; Umland et al., 2000),
except that, after denaturing Ni2-agarose purification and removal of the
amino terminal 6Xhis-tag with thrombin, BAF dimers were isolated by gel
filtration on Sephacryl S100 (Amersham) media and concentrated with Cen-
triprep-10 filtration units (Millipore, Bedford, MA). To induce the expression of
GST and GST-LEM, BL21 transformants were grown to an OD600 of 0.5 at 37°C
and induced at 30°C by the addition of IPTG to a final concentration of 1 mM.
Cells were lysed by sonication in bead binding buffer (50 mM sodium phosphate
[pH 7.5], 150 mM KCl, 1 mM MgCl2, 1% Triton X-100, 10% glycerol, 1 g/ml
leupeptin, 1g/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride [PMSF]). The
soluble fraction was retrieved after centrifugation at 15000  g for 20 min. The
concentration of GST and GST-LEM within these lysates was determined by
comparison with known amounts of GST in quantitative immunoblot analysis.
Affinity Purification of GST Proteins and GST
Coprecipitations
A GST or GST-LEM matrix was generated by incubating lysates containing 3
g GST or GST-LEM to 25 l glutathione Sepharose 4B beads (GS-4B;
Amersham) for 2 h at 4°C on an end-over-end rotator. Beads were washed
twice with 20 bed volumes binding buffer and used in BAF-binding reactions.
Binding reactions contained bead binding buffer, 25 l of GS-4B-GST or
-GST-LEM matrix, and unphosphorylated or phosphorylated BAF, in a total
volume of335 l. BAF protein samples were prepared in kinase reactions as
described in detail below, except that BAF was used at a concentration of 3
M and hVRK1 at 30 nM when present. Kinase reactions were terminated by
being placed on ice and brought to 10 mM EDTA. Unphosphorylated or
phosphorylated BAF, 1.2 g, was added to the immobilized GST or GST-
LEM, and incubations were allowed to continue at 4°C for 2 h with end-over-
end mixing. The beads were washed twice with bead-binding buffer; bound
proteins were eluted with SDS-PAGE sample buffer, resolved electrophoreti-
cally, and subjected to immunoblot analysis with -GST and -BAF (K.
Wilson) sera.
In Vitro Kinase Assays
Phosphorylation of Cell Lysates. BSC40 cells were disrupted by dounce
homogenization in ice-cold homogenization buffer (0.25 M sucrose, 10 mM
triethanolamine, 1 mM EDTA, and 10 mM KCl adjusted to pH 7.8 with 100
mM acetic acid), followed by the addition of Triton X-100, 1% final concen-
tration. Lysate from 5  106 cells was heat-inactivated at 65°C for 20 min
before the addition of kinase buffer (final concentrations: 50 mM Tris [pH 7.5],
1 mM dithiothreitol, 1 mM ATP [unless otherwise noted], 10 Ci [-32P]ATP,
3000 Ci/mmol) and 100 ng of B1 or hVRK1 kinase. Reactions were performed
at room temperature for 30 min before being stopped by the addition of
SDS-PAGE sample buffer. Reactions were then fractionated by SDS-PAGE; in
some cases, radiolabeled proteins were detected directly by autoradiography.
In other cases, the proteins were transferred electrophoretically to nitrocellu-
lose, and the filter was analyzed both by autoradiography and immunoblot
analysis with -BAF sera (K. Furukawa).
Phosphorylation of Purified BAF or GST-p53. Kinase assays utilizing purified
BAF or GST-p53 protein as a substrate were performed at room temperature
in 25-l reactions containing kinase buffer and the indicated concentrations of
enzyme and WT or mutant protein. After the indicated times, reactions were
stopped by the addition of SDS-PAGE sample buffer unless otherwise noted,
resolved by SDS-PAGE, and visualized by silver-staining, autoradiography and
PhosphorImager analysis (Molecular Dynamics, Sunnyvale, CA; Amersham).
Phosphoamino Acid Analysis. In vitro kinase reactions containing BAF and
B1 or VRK1 kinase were carried out for various times in the presence of 20 Ci
[32P]ATP and 125 M rATP. Reactions were resolved on a 17% SDS-poly-
acrylamide gel, transferred to Immobilon P membrane, and visualized by
autoradiography. Portions of the membrane corresponding to phosphory-
lated BAF were excised and hydrolyzed in situ in 100 l of constant boiling
HCl at 110°C for 1 h. Hydrolysates were resolved by thin layer electrophoresis
on a HTLE-7000 system (C.B.S. Scientific, Del Mar, CA) at 1800 V for 35 min,
as described previously (Traktman et al., 2000). Phosphoserine, phosphothreo-
nine, and phosphotyrosine standards were included and visualized by nin-
hydrin staining; radiolabeled amino acids were visualized by autoradiogra-
phy.
DNA-Binding Assays. Binding of BAF to DNA cellulose was assayed as
described before (Segura-Totten et al., 2002). Briefly, kinase reactions contain-
ing BAF and either B1 or VRK1 kinase were stopped at the indicated times by
the addition of 500 l ice-cold binding buffer (20 mM Tris [pH 7.4], 1 mM
EDTA, 100 mM NaCl [with the exception of Figure 5C, in which the NaCl
concentration was varied] and 0.1% NP-40) and 50 l native dsDNA cellulose
beads (Amersham). Incubations were allowed to continue overnight at 4°C
with end-over-end rotation. Beads were washed three times with binding buffer,
and bound proteins were eluted by the addition of SDS sample buffer. Proteins
were visualized by immunoblot analysis with -BAF sera (K. Furukawa). For
Figure 7A, 35S-labeled 3XFLAG-BAF was synthesized in vitro using a coupled
transcription/translation system (TnT, Promega, Madison WI) programmed
with pTM1–3XFLAG-BAF. Lysates were reacted with DNA cellulose as de-
scribed above and analyzed by SDS-PAGE and autoradiography.
Immunofluorescence
U2OS cells, 3  105, were seeded in a one-well chamber slide (Lab-Tek,
Naperville, IL) 1 d before transfection. Transfection complexes contained 10
l of Lipofectamine 2000 (Invitrogen) with 2 g either p3XFLAG-hVRK1 or
p3XFLAG-hVRK1 D177A and 2 g of either pAcGFP-BAF or pAcGFP-BAF
MAAAQ. In some cases, the BAF-expressing plasmid was administered in-
dividually along with empty vector. At 24 h posttransfection, cells were fixed
in 4% PFA, 4% sucrose in phosphate-buffered saline (PBS; 140 mM NaCl, 2
mM KCL, 10 mM Na2HPO4, 1 mM KH2PO4, [pH 7.4]) at room temperature
for 15 min, permeabilized with 0.2% Triton X-100 in PBS for 5 min at room
temperature and then blocked in 10% BSA in PBS for 30 min. Cells were then
reacted with -FLAG antibody at a dilution of 1:200 in 3% BSA in PBS,
followed by goat anti-mouse-594 (Molecular Probes) at 1:300 in PBS. DNA
was stained with DAPI; GFP-BAF was detected by direct fluorescence on
Nikon Eclipse TE2000-U microscope (Melville, NY). Images were pseudocol-
ored and labeled using Canvas 8 (Deneba Systems, Miami, FL).
Subcellular Fractionation and Immunoprecipitation
Cell Fractionation. Approximately 3  106 U2OS cells were transfected with
4 g of p3XFLAG-BAF or the indicated mutant plasmid and 4 g of
p3XFLAG-hVRK1, p3XFLAG-hVRK1 D177A, or empty vector using Lipo-
fectamine, 2000. At 24 h posttransfection the cells were resuspended in
ice-cold fractionation buffer (20 mM Tris pH 7.4, 5 mM MgCl2, 5 mM DTT, 150
mM KCl, and 0.5% Triton X-100) containing 1 mM NaF, 1 mM sodium
Table 1. Table of primers
Primera,b Sequence
BAFMTTSQ UP TAGGATCCCATATGACAACCTCCCAAA
AGC
BAFMTTAQ UP TAGAATTCaagcttCATATGACAACCGCCCA
AAAGCACCGAGAC
BAFMAASQ UP TAGAATTCaagcttCATATGGCAGCCTCCCA
AAAGCACCGAGAC
BAFMTTDQ UP TAGAATTCaagcttCATATGACAACCGACC
AAAAGCACCGAGAC
BAFMAAAQ UP TAGAATTCaagcttCATATGGCAGCCGCCC
AAAAGCACCGAGAC
BAF DN GCTGAATTCGGATCCTCACAAGAAGGCG
hVRK1Asp UP TCAGACggtaccACATATGCCTCGTGTAA
AGC
D177A UP GCATGGACTATCAAGGCCTCAAATCTTC
D177A DN CCTTGATAGCTCCATGCACATACTCATGC
hVRK1 DN CAGGATCCTTACTTCTGGACTC
Emerin UP1 CGATGGAAGCTTCATATGGACAACTACG
CAGATC
Emerin DN TAGGATCCCTAGAAGGGGTTGCCTTCTTC
Emerin UP2 CGTTGGATCCCATATGGACAACTACGCA
GATC
Emerin LEM DN AGGATCCCTAGAAGCTATAAGAGGAGG
a Primer-introduced mutations are indicated by underlined and
boldface type.
b Relevant restriction sites used in this study are indicated as fol-
lows: BamHI, boldface type; NdeI, italicized; HindIII, lowercase;
Asp718/KpnI lowercase boldface type.
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orthovanadate, 40 mM -glycerol phosphate, 1 g/ml leupeptin, 1 g/ml
pepstatin, and 1 mM PMSF. After 10 min of incubation on ice, sucrose was
added to 10% and the insoluble fraction was retrieved by centrifugation at 1000
g for 10 min. The supernatant, which contained the cytoplasmic/nucleosolic
fraction, and the pellet were resolved by SDS-PAGE and subjected to immuno-
blot analysis with -FLAG M2 antibody (Sigma). When indicated, cells were
radiolabeled by replacing the media with phosphate-free DMEM (MP Biomed-
ical, Irvine, CA) supplemented with 100 Ci/ml 32PPi from 20 to 24 h posttrans-
fection, and 3XFLAG-BAF was then retrieved from the soluble fraction of radio-
labeled extracts using M2 affinity agarose, washed, and eluted in SDS sample
buffer before analysis by immunoblot and autoradiography.
Immunoprecipitation and Phosphatase Treatment. Transfected cells were
harvested by scraping in PBS and lysed by incubation in 1 ml immunopre-
cipitation buffer (50 mM Tris [pH 7.4], 500 mM NaCl, 1% Triton-X 100, 0.1%
SDS, 1 mM EDTA with 1 mM NaF, 40 mM -glycerol phosphate and protease
inhibitors) for 15 min. Particulate matter was removed by centrifugation at
1000  g for 10 min. 3XFLAG BAF and mutants were immunoprecipitated
from the soluble fraction with rabbit -FLAG and protein A-Sepharose.
Immune complexes were washed twice with immunoprecipitation buffer and
twice with phosphatase pretreatment buffer (25 mM Tris [pH 7.4], 150 mM
NaCl, and 0.01% Brij-35; Pierce, Rockford, IL). On the final wash in this buffer,
complexes were divided and treated with or without  protein phosphatase
(New England Biolabs; Ipswich, MA) in the provided buffer. Immunoprecipi-
tates treated thus were analyzed by immunoblot analysis with mouse
-FLAG.
Computer Analysis
Autoradiography films were scanned using an Epson 1680 scanner (Epson,
Long Beach, CA). All sequence analyses were performed with Lasergene
Software (DNASTAR, Madison, WI). Figures were labeled using Canvas
software. Where immunoblot signal intensity comparisons are presented (i.e.,
Figures 4 and 5), chemiluminescent signals were gathered with a FlourChem
8800 and densitometry determined with FluorChem 8900 software (Alpha
Innotech, San Leandro, CA.). The BAF structural model in Figure 8 was
created using Cn3D 4.1 software and BAF structure PDB 1CI4.
RESULTS
VRKs represent a distinct branch of the casein kinase family
of serine/threonine kinases; they were so named because of
their high homology to the vaccinia B1 serine/threonine
kinase. The homology between these viral and eukaryotic
kinases led to the hypothesis that they might have overlap-
ping substrate specificities and hence overlapping functions.
Indeed, human, mouse and Drosophila VRK1 can comple-
ment the DNA replication defect that characterizes nonper-
missive infections performed with a vaccinia virus mutant
encoding a temperature-sensitive B1 protein (Boyle and
Traktman, 2004 and K. Boyle and P. Trakman, unpublished
results). Although there are no data implicating the VRKs in
cellular DNA replication per se, siRNA depletion of C.
elegans VRK leads to an early embryonic lethality character-
ized by impaired nuclear division (www.wormbase.org).
Likewise, mutations in the D. melanogaster homolog of VRK
(NHK1) result in defects in chromosomal segregation during
mitosis and meiosis (Cullen et al., 2005; Ivanovska et al.,
2005). The work described herein, therefore, was stimulated
by our hypothesis that the identification of substrates that
could be readily phosphorylated by both VRK1 and B1
would provide important clues as to the biological roles
performed by these kinases.
Phosphorylation of Whole Cell Lysates by the VRK1 and
B1 Kinases
As a first attempt to identify unknown cellular substrates for
VRK1 and B1, we performed in vitro kinase assays using
extracts of BSC40 cells as a source of substrates. The extracts
were heat-inactivated before being assayed so that only the
exogenously added kinases would direct the incorporation
of 32P-ATP into target substrates (Figure 1A). Few if any
phosphorylated species were observed when no exogenous
kinase was added; purified B1 kinase, in contrast, phosphor-
ylated many proteins within these extracts. When purified
VRK1 kinase was utilized in the same assay, only two phos-
phorylated proteins were observed. A 50-kDa species corre-
sponding to autophosphorylated VRK1 was seen, as was a
radiolabeled band migrating at 10 kDa. Interestingly, B1
also appeared to target a protein(s) of the same electro-
phoretic mobility (arrow).
Data generated in a yeast two-hybrid screen of the entire
Drosophila proteome had previously identified three proteins
as able to interact with the Drosophila VRK protein (Alvarez
et al., 1995; Giot et al., 2003). One was a protein of unknown
function, predicted to contain a bipartite nuclear localization
sequence and to have an unusually high (17%) proline con-
tent. A second protein identified was norpA, which has been
previously shown to have phospholipase activity (Alvarez et
al., 1995). The third protein, which showed the strongest
interaction with dVRK, was the D. melanogaster ortholog of
the DNA-binding protein Barrier to Autointegration Factor
(BAF). Mammalian BAF was originally identified as a 10-
kDa cellular protein that interacted with retrovirus preinter-
action complexes and prevented intramolecular recombina-
tion by the proviral DNA, thereby promoting integration of
the proviral DNA into the cellular genome (Lee and Craigie,
1994, 1998). Because BAF has a molecular weight similar to
the protein we observed being phosphorylated by VRK1 and
B1 in whole cell lysates (Figure 1A), we hypothesized that
the latter protein might indeed be BAF. We therefore ob-
tained an -BAF antibody from K. Furukawa, which we
used to perform immunoblot analyses of the same lysates
shown in Figure 1A. Immunoreactive species were visual-
ized by chemiluminescent detection, and phosphorylated
species were visualized by autoradiographic analysis of the
same filter. We observed three immunoreactive bands in the
samples that had been phosphorylated by the exogenous
kinases: one band comigrated with the band seen in un-
treated samples and the other two comigrated with the
32P-labeled bands.
VRK1 Phosphorylates Purified BAF In Vitro
The data described above strongly suggest that BAF present
within cellular extracts becomes phosphorylated when incu-
bated with the VRK1 or B1 kinases. To confirm this directly,
we purified recombinant BAF in a dimeric form and used it
as a substrate for in vitro kinase assays. These assays con-
tained 40 nM VRK1, 1 M BAF, and [-32P]ATP and were
performed for 0–60 min. For comparison, we performed
parallel assays using a GST-p53 fusion protein as a substrate.
Previous studies have described VRK1-mediated phosphor-
ylation of GST fusion proteins containing fragments of the
tumor suppressor protein p53 (Lopez-Borges and Lazo,
2000; Barcia et al., 2002; Vega et al., 2004); in particular, VRK1
has been shown to phosphorylate p53 on thr18 (Lopez-
Borges and Lazo, 2000). The reaction products were electro-
phoretically resolved, silver-stained to ensure that equal
levels of protein were present, and then excised from the gel
and subjected to C¸erenkov counting. As shown in Figure 1C,
VRK1-mediated phosphorylation of BAF was rapid and ro-
bust. In contrast, the autoradiographic signal for GST-p53
was nearly undetectable (inset), and at 60 min, 180-fold
more radiolabel had been incorporated into BAF than into
p53. Thus, VRK1 phosphorylates BAF with an efficiency that
greatly exceeds what is seen for GST-p53.
BAF Is Phosphorylated on ser4 and Less Efficiently on
thr2 and/or 3
The extreme N terminus of BAF is highly conserved in
different species and contains two thr and one ser residues
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that represent potential targets for phosphorylation (thr2,3
and ser4). As an initial test of whether this region of the
molecule might contain the site(s) of phosphorylation, we
used a coupled in vitro transcription/translation system to
express WT BAF and a variant in which residues 2–4 had
been replaced by an ala residue, and determined that VRK1
could phosphorylate the former but not the latter protein
(our unpublished data). To precisely map the sites of N-
terminal phosphorylation and determine the biochemical
impact of this modification, we generated alleles of BAF that
contained the following amino acid substitutions: MTTSQ
(WT) 3 MTTA4Q, MA2A3SQ, MTTD4Q, and MA2A3A4Q.
Using previously established protocols (Lee and Craigie,
1998; Umland et al., 2000), we induced the expression of
these proteins in E. coli and prepared purified preparations
of the dimeric form of the WT and mutant BAF proteins.
Each of the proteins analyzed displayed comparable chro-
matographic profiles.
VRK1-mediated Phosphorylation of BAF. We analyzed the
ability of VRK1 to phosphorylate the WT and mutant forms
of BAF by performing in vitro kinase assays for 0–120 min.
Reactions containing 3 nM VRK1 and 3 M BAF were re-
solved by SDS-PAGE and the BAF protein was visualized by
silver-staining (top panels) and autoradiography (bottom
panels), as shown in Figure 2A. For WT BAF, as the time
course of phosphorylation progressed, we observed the
original BAF protein (gray arrowhead) being converted to
two more slowly migrating species (black and white arrow-
heads). The middle species (black arrowhead) was observed
after only 1 min of phosphorylation, and 50% of the BAF
protein was present in this form after 2 min of phosphory-
lation. By 10 min, all of the protein had been shifted to this
middle species (corresponding to 1 phosphorylation event/
0.5 s). At this time, the most slowly migrating form (white
arrowhead) had also begun to appear; at 120 min, perhaps
20% of the total protein was present in this uppermost form.
The autoradiograph shows that both the middle and upper
forms did indeed represent phosphorylated species. A more
quantitative profile of phosphorylation is shown in Figure
2C, which shows a graphic representation of the level of
phosphorylation determined by phosphorimage quantita-
tion of each lane. The plot for VRK1-mediated phosphory-
lation of WT BAF is shown with black circles: a biphasic
profile is seen. The first phase, which is of 10 min in
duration, represents rapid and robust phosphorylation,
which corresponds to the generation of the middle species
shown in Figure 2A. A second slower phase then ensues,
with a gradual rise in 32P incorporation that continues until
120 min; this phase corresponds to the conversion of some of
the BAF protein to the uppermost form seen in Figure 2A.
We then performed parallel analyses of the mutant forms
of BAF in which the N-terminal ser and/or thr residues had
been changed to ala. When thr2, thr3, and ser4 were simul-
taneously changed to ala, the ability of VRK1 to phosphor-
ylate BAF was lost (Figure 2A, and lines with filled squares
in Figure 2C). These data confirm that all of the sites phos-
phorylated by VRK1 lie within this extreme N terminus of
Figure 1. BAF is a substrate for phosphorylation by recombinant
B1 and VRK1 kinases. (A) Phosphorylation of heat-killed cell lysates
by B1 and VRK1 kinases. Heat-killed lysates of BSC40 cells were
incubated with [-32P]ATP in the absence (no kinase) or presence of
purified vvB1 or hVRK1 kinases. Reaction products were resolved
electrophoretically and visualized by autoradiography; the numbers
at the left indicate the molecular weights of 14C-labeled protein
standards. Autophosphorylated hVRK1, and a protein postulated to
be BAF, are also indicated. (B) The BAF protein appears to become
phosphorylated in lysates treated with B1 or hVRK1. The reactions
shown in A were transferred to nitrocellulose and subjected to
immunoblot analysis with an -BAF serum (left panel) and autora-
diography. Unmodified BAF is indicated with a black arrow;
the two immunoreactive BAF species that comigrate with the
32P-labeled signal are indicated with gray arrows. (C) Recombinant
GST-p53 or dimeric BAF (1 M) were tested for their ability to serve
as hVRK1 substrates by performing in vitro kinase assays in the
presence of [-32P]ATP for 0–60 min. A graphic representation of
the incorporated radiolabel is shown. The corresponding silver-
stained gel and autoradiograph of the reactions performed with
GST-p53 is shown in the inset.
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Figure 2. In vitro phosphorylation of recombinant BAF by human VRK1, VRK2, and vvB1. Preparations of WT (MTTSQ) and mutant
(MAAAQ, MAASQ, MTTAQ, MTTDQ) BAF dimers (3 M) were used as substrates in in vitro kinase reactions performed with hVRK1 (A
and C), B1 (B and D), or VRK2 (E) in the presence of [-32P]ATP. In all cases, the substrate was present at 3 M and the enzyme at 3 nM;
reactions were performed for 0–120 min, as indicated. Reaction products were analyzed by SDS-PAGE and visualized by silver staining and
autoradiography (A and B); phosphorylation was also quantitated by phosphorimage analysis, as shown graphically in C–E. For A and B,
the gray arrowheads indicate the input protein, and the black and white arrowheads indicate electrophoretically distinct, phosphorylated
forms of BAF.
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BAF. Next, we examined the MAASQ allele, in which the
two thr residues had been altered. As shown in Figure 2A,
the middle species (black arrowhead) appeared with the
same kinetics seen with WT BAF, and all of the BAF protein
was converted to this species. As shown in Figure 2C (com-
pare lines with filled triangles and filled circles), the initial,
rapid phase of phosphorylation of the MAASQ protein was
indistinguishable from what we observed for WT BAF.
However, in this case, there was no second, slow phase
of phosphorylation—the levels of 32P incorporated had
reached a plateau after 10 min of phosphorylation, and no
upper species (white arrowhead) was seen by silver staining
or autoradiography. Thus, we conclude that the initial, rapid
phase of phosphorylation of WT BAF (and the appearance of
the middle form seen in Figure 2A) represents phosphory-
lation of ser4; the second phase of phosphorylation repre-
sents slow and incomplete phosphorylation of thr2 and/or
thr3. This conclusion was supported by the analysis of the
MTTAQ protein, in which the target ser residue had been
altered. Here, the rate of phosphorylation was significantly
slower (6-fold reduction in slope; Figure 2C, open circles)
and the ultimate level of 32P incorporation was approxi-
mately one-half of that seen with WT BAF. Examination of
the silver-stained gel and the autoradiograph confirms that
a single shifted species accumulated slowly. These data con-
firm that ser4 is the preferred site of phosphorylation and
that phosphorylation of thr2 and/or thr3 does occur, albeit at
a significantly slower rate. Finally, we examined the phos-
phorylation rate of the MTTDQ form of BAF, in which ser4
had been replaced with an asp in an attempt to observe the
rate of thr2 and/or thr3 phosphorylation when a negative
charge mimicking “prephosphorylation” was present at res-
idue 4. Under these circumstances, the rate of phosphoryla-
tion of thr2 and thr3 is slowed even further, suggesting that
the initial rapid phosphorylation of ser4 by VRK1 may in-
terfere with subsequent phosphorylation of thr2 and/or thr3.
These data may explain why only 20% of WT BAF under-
goes the thr phosphorylation events that generate the up-
permost species, whereas all of the MTTAQ protein can be
shifted to a phosphorylated form.
B1-mediated Phosphorylation of BAF. In light of our obser-
vation that the B1 kinase could also phosphorylate BAF in
whole cell lysates, we sought to compare its target sites with
those found for VRK1. Purified B1 was therefore incubated
with WT and mutants forms of BAF in kinase assays similar
to those described for VRK1. Again, phosphorylation was
monitored both by visualizing electrophoretic shifts (Figure
2B) and by quantitating 32P incorporation (Figure 2D). As
we had seen with VRK1, B1 induced the formation of two
phosphorylated forms of BAF that migrated more slowly
during SDS-PAGE. The rate of B1-mediated phosphoryla-
tion of WT BAF was also similar: 3 nM kinase could phos-
phorylate 3 M WT BAF in 10 min, as measured by a
complete shift of the unphosphorylated BAF to the middle
protein species (black arrowhead; Figure 2B, lane 5). B1
could not phosphorylate the BAF-MAAAQ protein, indicat-
ing that the site(s) for B1-mediated phosphorylation were
also contained within the extreme N terminus of BAF (Fig-
ure 2D, filled squares). Phosphorylation of the MAASQ vari-
ant by B1 closely approximated what had been seen with
VRK1; the initial rate of phosphorylation was the same as for
WT BAF (Figure 2D, filled triangles vs. filled circles), but the
second, slow phase of phosphorylation was absent and
hence a lower plateau was reached. Again, phosphorylation
of the MTTAQ variant proceeded significantly more slowly,
with a 10-fold decrease in the initial reaction rate. These
results for B1 closely mirrored those found for VRK1 and
indicate that B1 targets ser4 preferentially, but is able to
modify thr2 and/or 3 given additional time. Finally, we
assayed the rate at which B1 phosphorylates the BAF-
MTTDQ variant of BAF, in order to determine whether
substituting a negatively charged residue at the ser4 position
would impair the phosphorylation on thr2 and/or thr3, as
we had observed for VRK1. However, two shifted forms
were observed after phosphorylation (black and white ar-
rowhead, Figure 2B), and the rate of phosphorylation was
indistinguishable from that observed for the MTTAQ vari-
ant (Figure 2D, compare open triangles with open circles).
Thus, the presence of the asp residue at position 4 adversely
affected the phosphorylation of thr2 and/or thr3 by VRK1,
but not by B1.
BAF Is Also Phosphorylated by VRK2. We previously de-
scribed the relationship of the VRK paralogs to each other
and to the B1 kinase (Nichols and Traktman, 2004). The
VRK1 and VRK2 enzymes share a significant amount of
identity within their catalytic domains, and both are indeed
catalytically active. Although VRK1 is predominantly nu-
clear, VRK2 is found associated with the ER and the nuclear
envelope. Because the catalytic domains of VRK1 and VRK2
are closely related, we also assayed purified VRK2 kinase for
its ability to phosphorylate WT and variant preparations of
BAF in vitro. These data are shown graphically in Figure 2E.
VRK2 does indeed phosphorylate WT BAF with similar
kinetics to VRK1, and moreover, the pattern of phosphory-
lation obtained with the various BAF mutants is indistin-
guishable from what was observed with VRK1 (compare
Figure 2E with 2C).
Phosphoamino Acid Analysis. Further confirmation that
ser4 is the preferred site of phosphorylation by VRK1 and B1
was provided by performing phosphoamino acid analysis of
phosphorylated WT BAF or BAF-MTTAQ. In these reac-
tions, the total concentration of ATP was reduced eightfold
to allow us to increase the specific activity and hence aug-
ment the radioactive signal. Under these more limiting con-
ditions, only a single electrophoretically shifted species was
observed after VRK1-mediated phosphorylation of WT BAF
(unpublished data). The phosphoamino acid analysis indi-
cates that VRK1 only phosphorylates ser under these condi-
tions (Figure 3, lanes 1–3). Phosphoserine could be detected
Figure 3. Phosphoamino acid analysis of B1- and VRK1-phosphor-
ylated BAF proteins. WT BAF and the MTTAQ variant were phos-
phorylated in vitro by VRK1 or vvB1 for 1, 5, and 60 min. Reaction
products were resolved electrophoretically, transferred to PVDF,
excised, and processed for hydrolysis in situ. The hydrolysates were
subjected to high-voltage thin-layer electrophoresis in the presence
of phosphoamino acid markers (S, phosphoserine; T, phosphothreo-
nine; Y, phosphotyrosine). Radiolabeled phosphoamino acids were
visualized by autoradiography; the markers were visualized by
color development and are demarcated by ink wickets.
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by 1 min after the initiation of the kinase assay and increased
in abundance throughout the 60-min time course; in con-
trast, even after 60 min, 1% of the radiolabel was found at
the position of phosphothreonine. When the same analysis
was performed on BAF-MTTAQ (Figure 3, lanes 4–6), phos-
phoserine was no longer observed, as would have been
expected from the results shown in Figure 2. In contrast, the
appearance of phosphothreonine was accelerated. Thus,
phosphorylation of ser4 appears to diminish the efficiency
with which thr 2 and/or thr3 are phosphorylated.
When WT BAF was incubated with B1 (Figure 3, lanes
7–9), phosphoserine was detected in significant levels after 1
min of incubation and increased in intensity during the rest
of the time course; phosphothreonine was observed in sig-
nificant levels after 5 min of incubation and also increased
substantially during the rest of the time course. As expected,
we observed no phosphoserine when kinase reactions con-
taining BAF-MTTAQ and B1 were performed. Instead, phos-
phothreonine was observed in significant levels after 1 min
of incubation (Figure 3, lane 10). Thus, the B1 kinase also
phosphorylates thr2 and/or thr3 more rapidly in the absence
of ser4 phosphorylation, but its overall preference for ser4
versus thr2/3 is less absolute than is VRK1s under these
reaction conditions.
Phosphorylation of BAF Has a Modest Effect on Its
Interaction with the LEM Domain
BAF has been shown to form specific interactions with three
components of the inner nuclear envelope, Lap2, emerin,
and MAN1, through a common motif known as the LEM
domain (Acharya et al., 1996; Lee et al., 2001; Shumaker et al.,
2001; Holaska et al., 2003; Mansharamani and Wilson, 2005).
We were interested in determining whether phosphoryla-
tion of BAF might affect its interaction with the LEM do-
main. Glutathione sepharose beads containing immobilized
GST or GST-LEM were incubated with BAF or phosphory-
lated BAF, and the efficiency with which the BAF species
bound to the matrix was determined by immunoblot assay
(Figure 4). We consistently observed that 2–3-fold more un-
treated BAF bound to the immobilized GST-LEM than did
phosphorylated BAF. Thus, phosphorylation of BAF has a
modest but reproducible impact on the BAF-LEM interaction.
Phosphorylation of ser4 and/or thr2/3 Disrupts BAF’s
Ability to Bind DNA
A second and important property of BAF is its ability to bind
dsDNA tightly and without sequence preference. Previous
structure/function studies have implicated lys6 as participat-
ing in DNA binding (Harris and Engelman, 2000; Umland et
al., 2000; Segura-Totten et al., 2002); the proximity of this
residue to the MTTSQ motif was provocative. We therefore
probed the ability of untreated and phosphorylated BAF to
bind to a DNA cellulose affinity resin at near physiological
concentrations of NaCl (100 mM). BAF, 3 M, was preincu-
bated with or without ATP, in the presence or absence of
VRK1, for 7.5 or 90 min. These time points, selected based on
the time courses shown in Figure 2, were chosen to represent
either partially (primarily ser4) or fully (ser4 and thr2/3)
phosphorylated BAF. Parallel experiments were performed
using the B1 kinase, except that only a 60-min time point,
representing full phosphorylation of BAF, was used. Each of
these samples was then incubated with DNA-cellulose, and
the load and bound fractions were subjected to immunoblot
analysis (Figure 5). We observed that 50% of the untreated
BAF bound to the resin under these reaction conditions;
prior incubation with ATP alone or kinase alone did not
alter this profile. However, if BAF had been phosphorylated
by either B1 or VRK1, its ability to bind to DNA was severely
inhibited;0.5% of the input BAF bound to the resin (Figure
5, A and B, top panels). This effect was seen after 7.5 or 90
min of incubation with VRK1, suggesting that phosphory-
lation of ser4 was sufficient to abrogate DNA binding.
To gain further insight into the relationship between phos-
phorylation and the loss of DNA binding, similar studies were
performed with the BAF variants described above in Figure 2.
Figure 4. Phosphorylation of BAF decreases its association with the
LEM domain. GST or GST-LEM were bound to glutathione agarose
beads to generate affinity matrices, which were then incubated with
untreated BAF (unphos. BAF) or BAF that had been phosphorylated to
completion with hVRK1 (phos. BAF). Ten percent of the input proteins
(load) and 25% of the bound proteins (bound) were resolved by SDS-
PAGE and analyzed by immunoblot with -GST and -BAF.
Figure 5. Modification or mutation of ser4 and/or thr2,3 inhibits
the BAF:DNA interaction. (A and B) Purified preparations of WT or
mutant BAF dimers were incubated in the absence or presence of
hVRK1 (A) or vvB1 (B), with or without ATP, for the indicated
times. Ten percent of each reaction was removed and saved for
analysis as the load, and the remainder was incubated with DNA
cellulose beads in a buffer containing 100 mM NaCl. Both the load
(L) and bound (B) fractions were resolved electrophoretically and
subjected to immunoblot analysis with -BAF serum. (C) Untreated
preparations of WT BAF or the MTTAQ or MTTDQ variants were
incubated with DNA cellulose beads in buffers containing differing
concentrations of NaCl, as shown. The input (load) and bound
proteins were analyzed as described above.
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Untreated BAF-MTTAQ and BAF-MAASQ bound to the DNA
cellulose with similar efficiency to WT BAF, and both proteins
lost this ability after phosphorylation. These data indicate that
phosphorylation of either ser4 or thr2/3 by VRK1 or B1 is
capable of inhibiting BAF’s ability to bind DNA. The DNA
binding ability of BAF-MAAAQ, in contrast, was unaffected by
incubation with kinase  ATP. Somewhat surprisingly, un-
treated BAF-MTTDQ protein bound to DNA cellulose with the
same efficiency as WT BAF, despite the presence of an asp
residue at the position of ser4. Apparently, the presence of a
negative charge at this position does not have the same effect as
acquisition of a phosphate group. However, when the MTTDQ
protein was phosphorylated at thr2/3 with VRK1 or B1, it did
lose its ability to bind to the DNA cellulose.
Because of the unexpected observation that BAF-MTTDQ
was still able to bind to DNA cellulose under our experi-
mental conditions, we performed additional binding studies
in which WT and mutant BAF proteins were applied to the
DNA cellulose resin in the presence of increasing concentra-
tions of salt (Figure 5C). For WT BAF, raising the concen-
tration of NaCl to 700 mM salt only led to a 20% decrement
in the amount of protein that bound to the DNA cellulose
resin. These data agree with the previous observation that
BAF remains bound to retroviral PICs until 750 mM NaCl
is applied (Suzuki and Craigie, 2002). The binding of the
BAF-MTTAQ protein was somewhat more salt-sensitive;
increasing the salt concentration to 300, 500, or 700 mM
NaCl led to 38, 73, and 81% decreases in the amount of
protein that bound to the resin, respectively. The BAF-
MTTDQ protein was significantly more salt-sensitive; in the
presence of 300 mM salt, we observed an 80% decrease in the
amount of BAF bound to the DNA cellulose, and there was
a97% reduction when the salt was raised to 500 or 700 mM
NaCl. These data confirm that ser4 has an important role in
mediating the BAF-DNA interaction, and that modifications
to this residue have an inhibitory impact that follows the
hierarchy ser3pser  ser3asp  ser3ala.
The Phosphorylation Status and Subcellular Distribution
of BAF Changes upon Overexpression of VRK1
The data described above provide strong evidence that BAF
is an excellent substrate for VRK1-mediated phosphoryla-
tion and that this phosphorylation has a modest effect on the
interaction of BAF with LEM-containing proteins and a dra-
matic effect on its interaction with DNA. To obtain prelim-
inary corroboration that VRK1 would affect BAF in a similar
manner in vivo, we generated reagents that allowed the
expression of epitope-tagged VRK1 and/or BAF in cultured
cells. We prepared vectors that directed the expression of
3XFLAG-BAF, 3XFLAG-BAF-MAAAQ, GFP-BAF, and GFP-
BAF-MAAAQ. We also generated constructs expressing
3XFLAG-VRK1 and 3XFLAG-VRK1D177A; the amino acid
substitution in the latter allele affects a critical residue in-
volved in coordinating ATP via a Mg2 salt bridge and
hence ablates catalytic activity.
Analysis of endogenous VRK1, or transiently expressed
variants containing N or C epitope tags, has revealed that
the protein is found to be localized throughout the nucleus.
(Lopez-Borges and Lazo, 2000; Sevilla et al., 2004a, 2004b;
Nichols and Traktman, 2004). This nuclear localization was
seen once again when we transiently expressed 3XFLAG-
VRK1 on its own (unpublished data). Similar, transiently
expressed GFP-BAF or GFP-BAF MAAAQ localized to the
nucleus when expressed alone (Figure 6), as expected from
previous studies of BAF localization (Segura-Totten et al.,
2002; Shimi et al., 2004).
When 3XFLAG-VRK1 and GFP-BAF were introduced to-
gether, there was an increased pool of cytoplasmic BAF;
indeed BAF appeared to be found throughout the cell (ar-
rows, Figure 6). Surprisingly, in these cells, we also observed
that VRK1 was now dispersed throughout the cell. This
change in BAF localization was not seen when GFP-BAF was
coexpressed with the catalytically null VRK1D77A, indicating
that VRK1-mediated phosphorylation events were driving
the relocalization of BAF. Support for the conclusion that it
was the phosphorylation of BAF itself that was causing its
relocalization came from our observation that the GFP-BAF
MAAAQ protein retained its nuclear localization when co-
expressed with active VRK1 (or the catalytically inactive
variant; unpublished data). Because BAF-MAAAQ cannot
be phosphorylated by VRK1, these cumulative data imply
that the VRK1-mediated phosphorylation of BAF alters its
cellular localization.
We next sought to gain more direct evidence that the
intracellular localization of BAF was correlated with, or
regulated by, its phosphorylation status. To this end, we
used constructs encoding 3XFLAG BAF and first confirmed
that this epitope-tagged version retained the DNA-binding
properties of untagged BAF. 3XFLAG-BAF was synthesized
in vitro using a coupled transcription/translation protocol
and then incubated with DNA cellulose. Figure 7A shows
that 35S-labeled 3XFLAG BAF does indeed bind to DNA
cellulose. We then transiently transfected cells with the plas-
mid directing the expression of 3XFLAG-BAF, and metabol-
ically labeled the cells with 32PPi in order to monitor the
phosphorylation of BAF in vivo. Cell lysates were subjected
to immunoprecipitation with FLAG-agarose resin, and the
bound proteins were resolved electrophoretically, trans-
ferred to nitrocellulose, and visualized with both immuno-
blot analysis and autoradiography (Figure 7B). Two electro-
phoretically distinct forms of BAF were seen on the
immunoblot (black and white arrowheads), and a single
radiolabeled species that comigrated with the more slowly
migrating species (black arrowhead) was observed on the
autoradiograph. These data confirmed that transiently ex-
pressed BAF was indeed being phosphorylated in vivo by
endogenous kinases. To examine whether this phosphoryla-
tion was affecting thr2,3 and/or ser4, we performed parallel
transfections with plasmids expressing WT BAF (MTTSQ) or
variants in which thr2,3 and/or ser4 were mutated to ala
(MTTAQ, MAASQ, MAAAQ). The epitope-tagged proteins
were retrieved by immunoprecipitation, left untreated or
treated with  phosphatase, and then resolved electro-
phoretically and visualized by immunoblot analysis. As
shown in Figure 7C, the WT protein appeared as two dis-
tinct species of nearly equivalent abundance; upon phospha-
tase treatment, the abundance of the more slowly migrating
species was dramatically reduced (compare lanes 1 and 5). A
similar profile was seen for the MAASQ protein (Figure 7C,
lanes 2 and 6), although in this case the upper band was
somewhat less abundant in the untreated sample and absent
after phosphatase treatment. For the MTTAQ protein, a faint
but distinct upper band was observed, and this species was
also eliminated by phosphatase treatment (Figure 7C, lanes
3 and 7). These data provided confirmation that BAF was
indeed being phosphorylated in vivo, and supported the
conclusion that thr 2,3 and ser4 are minor and major deter-
minants, respectively, of the efficiency with which this mod-
ification occurs. For the MAAAQ treatment, only one species
was observed, and its mobility was not affected by phospha-
tase treatment (Figure 7C, lanes 4 and 8). This variant, which
was not a substrate for VRK-mediated phosphorylation in
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vitro (Figure 2), also does not appear to undergo detectable
phosphorylation in vivo.
These data also confirmed that we could use immunoblot
analysis to monitor the electrophoretically distinct unphos-
phorylated and phosphorylated BAF proteins. We therefore
used this assay to monitor the subcellular fractionation of
WT BAF and the MAAAQ variant. Cells were therefore
transfected with plasmids directing the expression of
3XFLAG-BAF or 3XFLAG-BAF MAAAQ, alone or with
plasmids directing the expression of VRK1 or VRK1D177A,
and then subjected to a limited Triton X-100 extraction fol-
lowed by centrifugation. The supernatant fraction has been
shown to contain soluble cytoplasmic and nucleoplasmic
proteins, whereas the pellet contains proteins associated
with the nuclear matrix, intermediate filaments, and chro-
matin (Okuno et al., 2001; Zaidi et al., 2001; Dreuillet et al.,
2002; Yoshizawa-Sugata et al., 2005). These fractions were
then subjected to immunoblot analysis with -FLAG serum
(Figure 7D). When 3XFLAG-BAF was expressed alone, it
was found in both the soluble and pellet fractions. However,
whereas the soluble fraction contained equivalent amounts
of the unphosphorylated and phosphorylated forms of BAF,
the pellet fraction was highly enriched for unphosphory-
lated BAF (lanes 1 and 2). The profile was quite different
when VRK1 was coexpressed with 3XFLAG-BAF. First, the
soluble fraction was now significantly enriched in phosphor-
ylated BAF (compare lanes 3 and 1), and there was a sharp
decrease in the total amount of BAF present in the pellet
fraction (compare lanes 4 and 2). These data indicate that, in
the presence of VRK1, significantly more BAF is phosphor-
ylated and that this protein is no longer fixed within an
insoluble nuclear compartment, but is in fact soluble. As
would be expected from this conclusion, expression of
VRK1D177A did not alter either the phosphorylation status or
fractionation profile of BAF (compare lanes 5,6 with 1,2).
When we examined the profile of 3XFLAG-BAF MAAAQ,
we found a single electrophoretic species corresponding to
unphosphorylated BAF; this protein, too, partitioned to both
the soluble and pellet fractions. Because this form of BAF
cannot be phosphorylated by VRK1, it was not surprising
that we observed no impact on its electrophoretic mobility
or subcellular fractionation when either VRK1 or VRK1D177A
was coexpressed (lanes 7–12). Together, these data indicate
that the extreme N terminus of BAF undergoes phosphor-
ylation in vivo and that this phosphorylation can be readily
modulated by the VRK1 kinase. They further indicate that
both soluble and insoluble pools of BAF are present within
cells. It is predominantly the unphosphorylated BAF that is
present in the insoluble pool, which probably corresponds to
an association with the nuclear matrix/chromatin. The
phosphorylated BAF is not found associated with these nu-
clear compartments, which is consistent with our findings
Figure 6. Expression of WT VRK1 results in
the relocalization of WT GFP-BAF to the cy-
toplasm of U2OS cells. U2OS cells were trans-
fected with plasmids directing the synthesis
of GFP-BAF or GFP-BAF-MAAAQ, with or
without plasmids directing the synthesis of
3XFLAG-hVRK1 or 3XFLAG-hVRK1D177A. At
24 h posttransfection, cells were fixed and
stained with -FLAG mAb and a fluorescent-
tagged secondary antibody, and DAPI. Rep-
resentative fields were photographed using
filters appropriate to visualize GFP-BAF,
VRK, and DNA. Bar, 50 m.
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that, in vitro, phosphorylation of BAF diminishes its inter-
action with LEM-containing proteins and virtually abolishes
its interaction with DNA (Figure 8).
DISCUSSION
Elucidation of the interactions between kinases and their
substrates is an essential step in gaining an understanding of
the intricate intracellular signal transduction cascades that
regulate cell biology. The cellular VRKs, and the related
vaccinia virus B1 kinase, define a distinct branch of the
casein kinase family whose biological roles remain to be
fully resolved. While screening cell lysates for common sub-
strates that could be phosphorylated by these enzymes, we
identified a 10-kDa protein that we were able to identify as
BAF. By performing an extensive series of in vitro kinase
reactions, we were able to determine that VRK1, VRK2, and
B1 can all phosphorylate the extreme N terminus of BAF.
Interestingly, the motif surrounding the phosphorylation
sites, MTTSQ, bears no resemblance to target sequences
within proteins that have been previously shown to be phos-
phorylated by VRK1 (p53, ATF2, cJUN) or B1 (vaccinia H5
protein; Brown et al., 2000; Lopez-Borges and Lazo, 2000;
Sevilla et al., 2004a, 2004b). Within BAF, ser4 is the preferred
target for these kinases, but thr2 and/or thr3 can also be
phosphorylated, albeit at a slower rate. Phosphorylation of
BAF occurs very rapidly and to completion, indicating that
BAF is modified very efficiently by these kinases. Coincident
with the submission of this article, Bengtsson and Wilson
(2005) published a report documenting the phosphorylation
of endogenous BAF in HeLa cells and Xenopus oocytes.
When recombinant BAF was added to Xenopus extracts, the
predominant site of phosphorylation was shown to be ser4,
although 2D gel analysis suggested that posttranslational
modification was also occurring at other sites. Our data are
consistent with and extend these findings.
Analysis of the structure of BAF by both NMR and x-ray
crystallography has provided a significant amount of insight
into the organization of the BAF dimer (Cai et al., 1998;
Umland et al., 2000). The LEM-binding domain has a saddle-
like conformation that is generated from both subunits of the
BAF dimer (Segura-Totten et al., 2002). Although this do-
main is quite removed from the N-termini that undergo
phosphorylation, mutations that affect several regions of the
protein have been shown to have an impact on the BAF-
Figure 7. Expression of WT 3XFLAG-VRK1 results in a release of
WT BAF from the insoluble nuclear matrix fraction of U2OS cells.
(A) 35S-labeled 3XFLAG-BAF, synthesized using an vitro transcrip-
tion/translation protocol, was incubated with DNA cellulose beads.
Ten percent of the input (load, L) and all of the bound (B) protein
were resolved electrophoretically and visualized by autoradiogra-
phy. (B) U2OS cells transfected with a plasmid directing the expres-
sion of 3XFLAG-BAF were metabolically labeled with 32PPi from 20
to 24 h posttransfection. Cell lysates were subjected to immunopre-
cipitation with -BAF antibody; immunoprecipitates were resolved
electrophoretically and transferred to nitrocellulose. Total BAF pro-
tein was visualized by immunoblot analysis using -BAF serum
(left box); radiolabeled BAF was visualized by autoradiographic
analysis of the same filter (right box). The open and filled arrow-
heads indicate the unphosphorylated and phosphorylated forms of
BAF, respectively. (C) 3XFLAG-BAF, 3XFLAG-MAASQ, 3XFLAG-
MTTAQ, and 3XFLAG-MAAAQ were expressed in U2OS cells by
transient transfection and immunoprecipitated using rabbit –FLAG
antibody. Immunoprecipitates were then treated with -phosphatase
(P’ase) or mock-treated and subjected to immunoblot analysis using
mouse -FLAG antibody. (D) U2OS cells were transfected with plas-
mids directing the expression of 3XFLAG-BAF or 3XFLAG-BAF-
MAAAQ with or without plasmids directing the expression of hVRK1
or hVRK1-D177A. At 24 h posttransfection, cells were lysed in buffer
containing 0.5% Triton X-100 and separated into soluble and insoluble
fractions by low-speed centrifugation. Equal volumes of both fractions
were subjected to immunoblot analysis with -FLAG antibody. The
open and filled arrowheads indicate the unphosphorylated and phos-
phorylated forms of BAF, respectively.
Figure 8. Model of BAF regulation. The interaction of BAF with
LEM domain–containing proteins within the inner nuclear mem-
brane, and with DNA, can be negatively regulated through the
phosphorylation of its N terminus by VRK1.
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LEM interaction (Segura-Totten et al., 2002). We were there-
fore not too surprised to find that phosphorylation of BAF
diminished the efficiency with which it interacted with a
GST-LEM fusion protein to a modest, but reproducible, ex-
tent. We assume that phosphorylation induces a subtle con-
formational change that in turn affects the LEM-binding
region. Bengtsson and Wilson (2005) have recently reported
that, in vitro, nonphosphorylated BAF interacts with lamin
A and enhances the interaction of emerin with lamin A,
whereas both of these activities are greatly reduced for
phosphorylated BAF (or a ser43glu variant designed to
mimic constitutive phosphorylation). Cumulatively, the
data from the Wilson laboratory and our laboratory suggest
that phosphorylation can modulate the interaction of BAF
with its known protein partners.
The N terminus of BAF is known to be intimately involved
in the interaction of BAF with DNA. In fact, analysis of a
BAF-DNA cocrystal has revealed that ser4 makes contact with
the phosphate backbone of the DNA via a water molecule
(Bradley et al., 2005). Phosphorylation of ser4, or indeed thr2/3,
virtually ablated the ability of BAF to bind to DNA. By varying
the concentrations of NaCl present in our DNA-binding assays,
we were able to show that the BAF-DNA interaction was
moderately weakened by mutation of ser4 to ala and further
weakened by mutation of ser4 to asp. The latter mutation,
which might have been predicted to mimic phosphorylation,
was not as deleterious to the BAF-DNA interaction as was
phosphorylation. Because lys6, gly25, and gly27, in concert with
other amino acids, form hydrogen bonds with phosphate
moieties on the DNA backbone (Bradley et al., 2005), it
may be that a phosphate moiety on ser4 competes directly
for these interactions.
In sum, our in vitro data indicated that B1 and both VRK1
and 2 could stoichiometrically convert BAF to a phosphor-
ylated form and that this modification blocked the DNA-
BAF interaction and diminished the LEM-BAF interaction.
To test the biological relevance of these findings, we moni-
tored the impact of 3XFLAG-VRK1 expression on the behav-
ior of 3XFLAG-BAF or GFP-BAF in tissue culture cells.
Although GFP-BAF was predominantly nuclear in its lo-
calization, coexpression of catalytically active VRK1 led to a
striking redistribution of the protein throughout the cell.
This effect was not observed when a catalytically inactive
VRK1 mutant was coexpressed with GFP-BAF. Likewise, the
nuclear localization of the GFP-MAAAQ variant, which can-
not be phosphorylated by the VRK or B1 kinases, was un-
affected by coexpression of catalytically active VRK1. We
speculated that VRK-mediated phosphorylation of BAF re-
leased it from nuclear DNA, causing it to assume a diffuse
localization throughout the cell.
We therefore performed more direct analyses of the im-
pact of VRK1 expression on the phosphorylation status and
nuclear anchoring of 3XFLAG-BAF. When transiently ex-
pressed in cells, 3XFLAG-BAF was found in two electro-
phoretically distinct forms that represent unphosphorylated
and phosphorylated species. When these cells were fraction-
ated using a method known to separate soluble cytoplasmic
and nucleoplasmic proteins from proteins rendered insolu-
ble because of an association with chromatin or the nuclear
matrix, the soluble fraction contained an equal amount of
both forms of BAF. In contrast, the insoluble fraction was
highly enriched in unphosphorylated BAF, which is what
would be expected if phosphorylation prevented the asso-
ciation of BAF with proteins of the inner nuclear membrane
and with DNA. When VRK1 was coexpressed with BAF,
two changes were observed: first, the amount of BAF recov-
ered in the insoluble fraction decreased dramatically and
second, the BAF found in the soluble fraction was largely in
the phosphorylated form. Neither of these changes occurred
when a catalytically null variant of VRK1 was introduced
along with BAF. These data provide strong evidence that
VRK1 can phosphorylate BAF in vivo. The exclusion of
phosphorylated BAF from the insoluble fraction is consis-
tent with our demonstration that, in vitro, phosphorylated
BAF does not bind to DNA and binds to LEM domain–
containing proteins with reduced efficiency.
The demonstration that phosphorylation affects the inter-
actions of BAF with protein and DNA is quite provocative,
because BAF plays distinct roles in regulating nuclear archi-
tecture during different phases of the cell cycle. During
interphase, BAF is implicated in anchoring chromatin to the
nuclear periphery and has been shown to interact with
chromatin-bound transcription factors (Wang et al., 2002;
Holaska et al., 2003). This nuclear pool of BAF would be
predicted to be unphosphorylated. We hypothesize that
this same pool of BAF becomes phosphorylated during
prophase, so that it is released from chromatin and from the
proteins of the inner nuclear membrane, permitting chroma-
tin condensation and nuclear envelope breakdown to begin.
This model is consistent with previous reports demonstrat-
ing that BAF is largely nuclear during interphase and as-
sumes a diffuse localization early in mitosis as the nuclear
membrane disassembles (Haraguchi et al., 2001; Dechat et
al., 2004). In contrast, BAF localizes to the core regions of
chromosomes at telophase, where it facilitates the recruit-
ment of LAP2 and/or emerin from the ER during the initial
stages of nuclear membrane reassembly (Haraguchi et al.,
2001). We would presume, therefore, that BAF must become
dephosphorylated at the onset of telophase. This model for
the cell cycle regulation of BAF closely mirrors other dy-
namic processes that occur at the nuclear envelope. At the
onset of mitosis, disassembly of the nuclear lamina is trig-
gered by sequential phosphorylation events mediated by
protein kinase C (PKC) followed by the CDK1/cyclinB
complex (Heald and McKeon, 1990; Peter et al., 1990; Foisner
and Gerace, 1993; Goss et al., 1994; Thompson and Fields, 1996;
Collas et al., 1997). The LEM domain–containing proteins
Lap2 and emerin have also been reported to be differen-
tially phosphorylated in a cell cycle– dependent manner;
these modifications are capable of inducing dissociation
from DNA and BAF, respectively (Gajewski et al., 2004;
Hirano et al., 2005). These phosphorylation events are
mediated by multiple kinases and are part of a wave of
mitotic action that occurs during nuclear envelope break-
down, which is later reversed at the onset of nuclear
reassembly by protein phosphatases such as protein phos-
phatase-1 (Thompson et al., 1997).
Our in vitro and in vivo data strongly implicate the VRK
kinases in this cycle of BAF phosphorylation. It remains to
be determined whether the localization and/or activity of
VRK1 or VRK2 are themselves regulated in a cell cycle–
dependent manner. It has been shown that the Drosophila
VRK ortholog, NHK1, phosphorylates the H2A histone ex-
clusively during mitosis (Aihara et al., 2004), suggesting that
its activity may peak at this stage of the cell cycle. Our data
also suggest that overexpression of VRK1, or mis-regulation
of its activity, could have highly deleterious effects on vari-
ous aspects of the cell cycle, including nuclear disassembly,
chromosome partitioning, and nuclear reassembly. The
studies presented herein set the stage for further dissection
of the temporal and spatial interactions between the VRKs
and BAF, and for consideration of the full implication of
these interactions for regulation of nuclear structure and
function.
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